LOS ANGELES -- (Business Wire)
Glancy
Prongay & Murray reminds investors that a class action has been
filed on behalf of investors in Insulet Corp. (“Insulet” or the
“Company”) (NASDAQ: PODD), who purchased Insulet securities between
February 27, 2013 and April 30, 2015, inclusive (the “Class Period”).
Insulet investors have until July 6, 2015 to file a lead plaintiff
motion.
Insulet is primarily engaged in the development, manufacturing and sale
of its proprietary OmniPod Insulin Management System (the “OmniPod
System”), an insulin infusion system for people with insulin-dependent
diabetes.
The complaint filed against the Company alleges that Defendants made
false and/or misleading statements, as well as failed to disclose
material adverse facts about the Company’s business, operations, and
prospects. Specifically, Defendants failed to disclose: (1) that the
Company was experiencing slower demand for its products; (2) that the
Company was facing issues with its sales and marketing efforts; (3)
that, as a result, the Company experienced unevenness in its financial
performance; and (4) that, as a result of the foregoing, Defendants’
positive statements about the Company’s business, operations, and
prospects lacked a reasonable basis. As a result of Defendants’ wrongful
acts and omissions, and the precipitous decline in the market value of
the Company’s securities after disclosing the decline in its revenues,
investors have suffered significant losses and damages.
If you purchased Insulet shares or have information or would like to
learn more about these claims, or have any questions concerning this
announcement, please contact Lesley
Portnoy, of Glancy Prongay & Murray, 1925 Century Park East, Suite
2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at
888-773-9224, by email to shareholders@glancylaw.com,
or visit our website at http://www.glancylaw.com.
If you inquire by email please include your mailing address, telephone
number and number of shares purchased.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150701006740/en/
Contacts:
Glancy Prongay & Murray, Los Angeles
Lesley Portnoy
310-201-9150
or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com
Source: Glancy Prongay & Murray
© 2024 Canjex Publishing Ltd. All rights reserved.